US President Biden signs executive order supporting generic and biosimilar drugs

Jul 9, 2021

US President Biden signed an executive order aimed at promoting competition in the US economy. The order directs the Health and Human Services Administration (HHS) to increase support for generic and biosimilar drugs, and encourages the FTC to ban ‘pay for delay’ agreements.

Print Page Mail Article